Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GM Pharma (GM Pharmaceuticals) is a leading international pharmaceutical company headquartered in Tbilisi, Georgia, and is the largest manufacturer of medicines in the Caucasus region. Established in 2000, the company operates a state-of-the-art production facility that complies with international Good Manufacturing Practice (GMP) standards. GM Pharma specializes in the development, manufacturing, and marketing of a broad portfolio of over 100 high-quality generic medications across diverse therapeutic areas, including cardiology, neurology, gastroenterology, and endocrinology. The company has a significant international footprint, exporting its products to more than 10 countries across the CIS and Middle East. In addition to its own product line, GM Pharma provides contract manufacturing services and maintains strategic partnerships with global pharmaceutical companies for regional distribution and representation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GM Pharma.